Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan; Department of Research Planning and Information Management, Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan.
Heart Lung Circ. 2021 Jul;30(7):963-970. doi: 10.1016/j.hlc.2020.11.012. Epub 2021 Jan 16.
It is unclear whether women have a higher risk of stroke than men. This study aimed to clarify the effects of a sex difference on the risk of ischaemic stroke in patients with atrial fibrillation (AF).
Health check and insurance claims data were used of people who were aged <75 years from 2005 to 2017 in Japan. Patients with AF who were not on anticoagulation therapy were identified. After excluding patients with artificial valves (n=28), haematological disease (n=1,124), aged ≤20 years (n=207), and taking anticoagulant therapy (n=11,848), 9,733 remained for inclusion into the study. The primary outcome was hospital admission due to ischaemic stroke.
Of the 9,733 participants, 7,079 (72.7%) were men. The mean age of women (54.4 years) was significantly higher than that of men (53.2 years). During a mean 2.5-year follow-up period, 143 ischaemic stroke events occurred. Female sex was not associated with ischaemic stroke (adjusted hazard ratio [95% confidence interval]: 1.13 [0.78-1.66]). When stratified using the CHADS-VASc score, the annual incidence of ischaemic stroke was similarly low among women with a CHADS-VASc score of 1 (0.8%) and men with a score of 0 (0.7%). The incidence of ischaemic stroke increased with a CHADS-VASc score of 2 in women and 1 in men.
In this large-scale, real-world study of patients with AF, the risk of ischaemic stroke among those aged <75 years was comparable between women and men. These findings are consistent with the current guidelines, which do not recommend anticoagulant therapy for women with no other risk factors (CHADS-VASc score of 1).
目前尚不清楚女性患中风的风险是否高于男性。本研究旨在阐明性别差异对伴有心房颤动(AF)的缺血性中风风险的影响。
使用日本 2005 年至 2017 年期间年龄<75 岁的健康检查和保险理赔数据,确定未接受抗凝治疗的 AF 患者。排除人工瓣膜(n=28)、血液疾病(n=1124)、年龄≤20 岁(n=207)和接受抗凝治疗的患者(n=11848)后,9733 例患者纳入研究。主要结局是因缺血性中风住院。
9733 名参与者中,7079 名(72.7%)为男性。女性(54.4 岁)的平均年龄明显高于男性(53.2 岁)。在平均 2.5 年的随访期间,发生了 143 例缺血性中风事件。女性性别与缺血性中风无关(调整后的危险比[95%置信区间]:1.13[0.78-1.66])。当使用 CHADS-VASc 评分分层时,CHADS-VASc 评分为 1 的女性和评分为 0 的男性的缺血性中风年发生率相似(女性为 0.8%,男性为 0.7%)。随着 CHADS-VASc 评分的增加,女性中风的发生率为 2,男性中风的发生率为 1。
在这项针对 AF 患者的大规模真实世界研究中,年龄<75 岁的患者中,女性和男性的缺血性中风风险相当。这些发现与当前指南一致,即对于无其他危险因素(CHADS-VASc 评分为 1)的女性,不建议抗凝治疗。